Regulatory-compliant and phase-appropriate (discovery, preclinical, clinical and commercial) analytical method development and quality control strategy
We have a dedicated and professional ARD team with over a decade of experiences and a successful track record in developing and
validating compliant and clinical phase-appropriate analytical methods. Our
services include analytical method development and optimization, analytical
method transfer and validation, stability studies, reference standards
characterization, release testing, quality control strategy development etc.
Our dedicated ARD team has a thorough understanding of the latest regulatory requirements, relevant chemistry and analytical knowledge which are essential in developing efficient, accurate and robust analytical methods.
The ARD team interacts closely with PRD team to understand process requirements in order to quickly develop appropriate analytical methods for monitoring reactions and final product testing. Our team has extensive experience and knowledge in developing analytical methods for chiral compounds, as well as in developing methods for trace residue detection such as genotoxic impurities (GTIs) and nitrosamine detection.
The analytical methods are validated by a team under GMP with QA supervision and in accordance with the appropriate phase requirements and ICH norms. During the validation of the analytical method, the team performs all activities as required by the client, including the review and approval of the validation protocol and report.
Our ARD service includes but are not limited to:
Partial list of key analytical instruments we use: